The prognostic significance of FZD2 was further validated using Kaplan-Meier analysis in GEO datasets, where gastric cancer patients with elevated FZD2 mRNA levels exhibited worse prognoses compared to those with lower levels. The gene discussed is FZD2; the disease is gastric cancer.